Amivantamab
Products in Health Canada’s databases that list Amivantamab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 5
- 5 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 9
- Products in all
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| RYBREVANT (350 MG) | 02526182 | Marketed | Janssen Inc. | |
| RYBREVANT SC (1600 MG) | 02569140 | Marketed | Janssen Inc. | |
| RYBREVANT SC (2240 MG) | 02569159 | Marketed | Janssen Inc. | |
| RYBREVANT SC (2400 MG) | 02569167 | Marketed | Janssen Inc. | |
| RYBREVANT SC (3520 MG) | 02569175 | Marketed | Janssen Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- RYBREVANTAugust 27, 2026 · NOC 38186
- RYBREVANT; RYBREVANT SCJune 18, 2026 · NOC 37731
- RYBREVANTJanuary 12, 2026 · NOC 36714
- RYBREVANTNovember 4, 2025 · NOC 36331
- RYBREVANTJuly 16, 2025 · NOC 35677
- RYBREVANTJanuary 13, 2025 · NOC 34686
- RYBREVANTJune 28, 2024 · NOC 33535
- RYBREVANTJuly 11, 2023 · NOC 31168
- RYBREVANTMarch 30, 2022 · NOC 27857